Ribon Therapeutics
OverviewSuggest Edit
Ribon Therapeutics is pioneering the discovery and development of monoPARP (mono ADP-ribose polymerase) inhibitors to block cancer cells’ fundamental ability to survive under stress
| Type | Private | |
| Founded | 2015 | |
| HQ | Lexington, US | Map |
| Website | ribontx.com | |
| Employee Ratings | More |
Latest Updates
| Employees (est.) (May 2019) | 31 | (-3%) |
Key People/Management at Ribon Therapeutics
Victoria Richon
Heike Keilhack
Kevin Kuntz
David Cordo
Ribon Therapeutics Office Locations
Ribon Therapeutics Financials and Metrics
Summary Metrics
Founding Date | 2015 |
Ribon Therapeutics investors | U.S. Venture Partners (USVP) |
Ribon Therapeutics Blogs
Ribon Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer
Laboratory and Facilities Manager
Director, DMPK
Senior Scientist/Principal Scientist, Medicinal Chemistry
Ribon Therapeutics Frequently Asked Questions
When was Ribon Therapeutics founded?
Ribon Therapeutics was founded in 2015.
Who are Ribon Therapeutics key executives?
Ribon Therapeutics's key executives are Victoria Richon, Heike Keilhack and Kevin Kuntz.
How many employees does Ribon Therapeutics have?
Ribon Therapeutics has 31 employees.
Who are Ribon Therapeutics competitors?
Competitors of Ribon Therapeutics include Aileron Therapeutics, Gamida Cell and Outlook Therapeutics.
Where is Ribon Therapeutics headquarters?
Ribon Therapeutics headquarters is located at 99 Hayden Ave, Lexington.
Where are Ribon Therapeutics offices?
Ribon Therapeutics has an office in Lexington.
How many offices does Ribon Therapeutics have?
Ribon Therapeutics has 1 office.